BVXV

BiondVax Pharmaceuticals Share Price - BVXV

3.55
-0.07 (-1.93%)
3.55
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
BiondVax Pharmaceuticals Ltd BVXV NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.07 -1.93% 3.55 18:29:32
Open Price Low Price High Price Close Price Prev Close
3.65 3.0981 3.74 3.63 3.62
Bid Price Ask Price Spread News
3.55 3.68 0.13 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,694 384,374  3.50  1,345,299 1,182,849 2.35 - 62.00
Last Trade Time Type Quantity Stock Price Currency
18:30:39 formt 150  3.55 USD

BiondVax Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 40.92M 11.53M 11.53M  -  - -3.82 -2.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News BiondVax Pharmaceuticals

Date Time Source Heading
3/04/202113:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/24/202116:58Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/17/202116:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/11/202106:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/10/202116:30PR Newswire (US)BiondVax Announces Exercise in Full of Underwriter's..
2/09/202106:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
2/08/202114:55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

BVXV Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.
Your Recent History
NASDAQ
BVXV
BiondVax P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210306 00:12:56